R6	Anaphora Anaphor:T10 Antecedent:T2
R7	Anaphora Anaphor:T39 Antecedent:T4
T2	Drug 298 304	THIOLA
T4	Drug 3408 3414	THIOLA
T48	SPAN 334 342	patients
T49	SPAN 2209 2222	complications
T5	ZeroArticleNP 0 10	Drug Label
T6	ZeroArticleNP 15 32	drug brand Thiola
T7	DefiniteNP 78 85	The use
T8	DefiniteNP 178 201	the anticipated benefit
T9	IndefiniteNP 348 363	a prior history
T10	DemonstrativeNP 434 449	this medication
T11	PossessivePronoun 507 520	their infants
T12	DefiniteNP 610 639	the serious adverse reactions
T13	IndefiniteNP 754 769	a fatal outcome
T14	DemonstrativeNP 850 868	such complications
T15	ZeroArticleNP 821 844	d-penicillamine therapy
T16	DefiniteNP 983 1006	the granulocytic series
T17	IndefiniteNP 1099 1121	an idiosyncratic basis
T18	DefiniteNP 1123 1136	The reduction
T19	ZeroArticleNP 1265 1272	therapy
T20	DefiniteNP 1323 1337	the occurrence
T21	IndefiniteNP 1341 1352	any symptom
T22	DemonstrativeNP 1364 1397	these hematological abnormalities
T23	IndefiniteNP 1582 1601	A close observation
T24	DefiniteNP 1637 1664	The following complications
T25	ZeroArticleNP 1705 1728	d-penicillamine therapy
T26	ZeroArticleNP 2065 2079	THIOLA therapy
T27	PersonalPronoun 2287 2291	them
T28	DefiniteNP 2180 2205	the potential development
T29	DefiniteNP 2246 2260	the occurrence
T30	IndefiniteNP 2264 2275	any symptom
T31	DefiniteNP 2334 2353	the following tests
T32	DefiniteNP 2664 2682	the first 6 months
T33	DefiniteNP 2688 2713	the optimum dose schedule
T34	DefiniteNP 2843 2851	the size
T35	IndefiniteNP 2817 2831	a yearly basis
T36	DefiniteNP 3143 3152	the fetus
T37	DefiniteNP 3275 3284	the fetus
T38	DefiniteNP 3325 3333	the dose
T39	DefiniteNP 3461 3469	the drug
T40	DefiniteNP 3522 3533	the highest
T41	IndefiniteNP 3361 3385	A similar teratogenicity
T42	DemonstrativeNP 3424 3440	no such findings
T43	DefiniteNP 3675 3696	the potential benefit
T44	DefiniteNP 3725 3734	the fetus
T45	PossessivePronoun 3921 3934	their infants
T46	DefiniteNP 3810 3849	the potential serious adverse reactions
T47	DefiniteNP 3985 3992	the age
